Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013;6(2):179-90.
Epub 2013 Jan 15.

Nectin-2 and DDX3 are biomarkers for metastasis and poor prognosis of squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder

Xiongying Miao  1 , Zhu-Lin Yang, Li Xiong, Qiong Zou, Yuan Yuan, Jinghe Li, Lufeng Liang, Meigui Chen, Senlin Chen
Affiliations

Nectin-2 and DDX3 are biomarkers for metastasis and poor prognosis of squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder

Xiongying Miao et al. Int J Clin Exp Pathol. 2013.

Abstract

The clinicopathological and biological characteristics of squamous cell/adenosquamous carcinoma (SC/ASC) of gallbladder have not been well documented because it is a rare subtype of gallbladder cancer. In this study, the protein expression of Nectin-2 and DDX3 in 46 SC/ASCs and 80 adenocarcinomas was measured using immunohistochemistry. We demonstrated that positive Nectin-2 and DDX3 expression was significantly associated with large tumor size, high TNM stage, and lymph node metastasis of SC/ASC and AC. Positive Nectin-2 and DDX3 expression was significantly associated with invasion and surgical curability of AC. Univariate Kaplan-Meier analysis showed that positive Nectin-2 and DDX3 expression, degree of differentiation, tumor size, TNM stage, invasion, lymph node metastasis, and surgical curability were significantly associated with post-operative survival in both SC/ASC and AC patients. Multivariate Cox regression analysis showed that positive Nectin-2 and DDX3 expression, degree of differentiation, tumor size, TNM stage, invasion, lymph node metastasis, and no surgical curability are independent poor-prognostic factors in both SC/ASC and AC patients. Our study suggested that positive Nectin-2 and DDx3 expression is closely correlated with clinical, pathological, and biological behaviors as well as poor-prognosis of gallbladder cancer.

Keywords: DDX3; Gallbladder cancer; Nectin-2; adenocarcinoma; adenosquamous carcinoma; metastasis; prognosis; squamous cell carcinoma.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Nectin-2 and DDX3 expression in SC/ASC. EnVision immunohistochemistry, original magnification x200. Nectin-2 and DDX3 positive reaction was mainly localized in the cytoplasm. A: Positive Nectin-2 expression in moderately differentiated SC/ASC. B: Negative Nectin-2 expression in well differentiated SC/ASC. C: Positive DDX3 expression in moderately differentiated SC/ASC. D: Negative DDX3 expression in well differentiated SC/ASC.
Figure 2
Figure 2
Nectin-2 and DDX3 expression in AC. EnVision immunohistochemistry, original magnification x200. Nectin-2 and DDX3 positive reaction was mainly localized in the cytoplasm. A: Positive Nectin-2 expression in moderatelydifferentiated AC. B: Negative Nectin-2 expression in well differentiated AC. C: Positive DDX3 expression inmoderately differentiated AC. D: Negative DDX3 expression in well differentiated AC.
Figure 3
Figure 3
Nectin-2 and DDX3 expression and survival in patients with SC/ASC of gallbladder. A: Kaplan-Meier plots of overall survival in patients with SC/ASC and with Nectin-2 positive and negative expression. B: Kaplan-Meier plots of overall survival in patients with SC/ASC and with DDX3 positive and negative expression.
Figure 4
Figure 4
Nectin-2 and DDX3 expression and survival in patients with AC of gallbladder. A: Kaplan-Meier plots of overall survival in patients with AC and with Nectin-2 positive and negative expression. B: Kaplan-Meier plots of overall survival in patients with AC and with DDX3 positive and negative expression.
See this image and copyright information in PMC

References

    1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics 2008. CA Cancer J Clin. 2008;58:71–96. - PubMed
    1. Jayaraman S, Jarnagin WR. Management of gallbladder cancer. Gastroenterol Clin North Am. 2010;39:331–342. - PubMed
    1. Reid KM, Ramos-De la Medina A, Donohue JH. Diagnosis and surgical management of gallbladder cancer: a review. J Gastrointest Surg. 2007;11:671–81. - PubMed
    1. Hawkins WG, DeMatteo RP, Jarnagin WR, Ben-Porat L, Blumgart LH, Fong Y. Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Ann Surg Oncol. 2004;11:310–315. - PubMed
    1. Ootani T, Shirai Y, Tsukada K, Muto T. Relationship between gallbladder carcinoma and the segmental type of adenomyomatosis of the gallbladder. Cancer. 1992;69:2647–52. - PubMed

MeSH terms